
    
      An open-label, randomized, cross-over study comparing the efficacy of zolmitriptan 5 mg nasal
      spray with eletriptan 40 mg tablet at early time points. Satisfaction endpoints include
      global assessment of preference, overall satisfaction and effectiveness as well as
      tolerability of both medications.
    
  